Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Galactosialidosis

Endocrine, Nutritional and Metabolic Diseases

Galactosialidosis, also known as neuraminidase deficiency with beta-galactosidase deficiency, is a genetic lysosomal storage disease. It is caused by a mutation in the CTSA gene, which leads to a deficiency of the enzymes beta-galactosidase and neuraminidase. Without them the lysosomes of cells cannot function properly, and toxic matter accumulates inside the cell. Hallmark symptoms include abnormal spinal structure, vision problems, coarse facial features, hearing impairment and intellectual disability. Because the lysosomes of all cells are involved, the disease can affect the brain, eyes, bones and muscles. Depending on the patient's age at the onset of symptoms it is divided into three subtypes: early infantile, late infantile, and juvenile or adult. The condition is considered rare, with most reported cases in the juvenile or adult group.

Facts
Classification
Body System
Skeletal System 1
Body System
Muscular System 1
Body System
Nervous System 1
Body System
Eye 1
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 1
Communicable or Non-communicable
Non-Communicable 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Sources
1. Galactosialidosis (Wikipedia)
  • Lead paragraph
    It is caused by a mutation in the CTSA gene
  • Lead paragraph [body-system]
    it can affect various areas of the body, including the brain, eyes, bones, and muscles
  • lead sentence 1
    Galactosialidosis, also known as neuraminidase deficiency with beta-galactosidase deficiency, is a genetic lysosomal storage disease.
  • Lead: disease category
    Galactosialidosis, also known as neuraminidase deficiency with beta-galactosidase deficiency, is a genetic lysosomal storage disease.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.